Nerve Block Catheter Set
Commercial- Indications
- Surgical pain, Post-operative pain, Pre-operative pain, Perioperative pain
Company intelligence / Profile preview
Ancora Medical developed an FDA-approved nerve block catheter set designed to improve reliability in operative nerve block administration. The device allows precise location of peripheral nerves using electrical impulses or ultrasound guidance. It aims to reduce opioid use by providing extended local anesthetic delivery for up to 72 hours post-surgery. The company was launched as a spin-off from SRI International with collaboration from Stanford University physicians and engineers. Its technology addresses unmet needs in surgical pain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ancora Medical Inc..